Cargando…
Risk–benefit analysis of COVID-19 vaccines — a neurological perspective
Rare neurological complications can occur after COVID-19 vaccination, but recent studies show that such complications are much more common after SARS-CoV-2 infection. Novel approaches to risk–benefit analysis such as Bayesian network models can integrate the latest global evidence with local factors...
Autores principales: | Lau, Colleen L., Galea, Ian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8687148/ https://www.ncbi.nlm.nih.gov/pubmed/34931027 http://dx.doi.org/10.1038/s41582-021-00606-5 |
Ejemplares similares
-
Counting the neurological cost of COVID-19
por: Baig, Abdul Mannan
Publicado: (2021) -
Looking for lights in the fog of long-term neurological COVID
por: Padovani, Alessandro, et al.
Publicado: (2022) -
High risk of autoimmune diseases after COVID-19
por: Sharma, Chetan, et al.
Publicado: (2023) -
CKD is a key risk factor for COVID-19 mortality
por: Gansevoort, Ron T., et al.
Publicado: (2020) -
Effects of ketosis in mitochondrial myopathy: potential benefits of a mitotoxic diet
por: Pitceathly, Robert DS, et al.
Publicado: (2016)